Anti Diabetic Medicine

Approx. Rs 21,000 / BoxGet Latest Price

Product BrochureProduct Details:

MOUNJARO 5MG (TIRZEPATIDE) KWIKPEN is an innovative, once-weekly injectable treatment used primarily for type 2 diabetes management. It helps improve blood sugar levels and supports significant weight reduction. Its dual-action formula sets it apart in modern metabolic therapy.

Product Full Description:

MOUNJARO 5MG (TIRZEPATIDE) KWIKPEN is a GLP-1 and GIP receptor agonist used for glycemic control in adults with type 2 diabetes. Its unique mechanism targets two key hormone pathways to help regulate insulin, reduce appetite, and promote weight loss. The pre-filled KwikPen ensures easy, accurate, and convenient self-injection. Each pen contains a single 5mg dose of tirzepatide and is designed for once-weekly use under medical guidance.

Usage Instructions:

1. Wash your hands and inspect the pen before use.

2. Select an injection site (abdomen, thigh, or upper arm).

3. Clean the site with alcohol.

4. Inject the dose once weekly, on the same day each week.

5. Dispose of the pen safely after use.

Always follow your healthcare provider’s dosing schedule.

Medicinal Advantages:

• Blood Sugar Control: Helps reduce HbA1c levels effectively in type 2 diabetes patients.

• Weight Management: Shown to significantly support weight loss through appetite regulation.

• Cardiometabolic Health: May improve overall cardiovascular risk markers.

• Dual Hormonal Action: Unique dual-incretin therapy (GLP-1 & GIP) for superior outcomes.

• User-Friendly Delivery: Pre-filled, ready-to-use pen for hassle-free self-administration.

Mechanism of Action:

MOUNJARO 5MG (TIRZEPATIDE) mimics two natural gut hormones—GLP-1 and GIP. These hormones increase insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite. This dual-hormone targeting enhances glucose control and encourages weight loss more effectively than single-action GLP-1 medications.

Off-Label Uses:

While primarily used for type 2 diabetes, MOUNJARO 5MG is being researched and used off-label for:

• Obesity in non-diabetics

• Polycystic Ovary Syndrome (PCOS)

• Prediabetes management

• Metabolic syndrome

These uses should be under specialist guidance.

Expert Advice:

• Always take the medication at the same time weekly.

• Do not skip doses; set a reminder if needed.

• Consult your healthcare provider before adjusting the dose.

• Monitor your blood sugar regularly.

• Combine with a balanced diet and physical activity for best results.

Precautions:

1. Not for Type 1 Diabetes – This medication is not suitable for patients with type 1 diabetes or diabetic ketoacidosis.

2. Avoid During Pregnancy – Safety in pregnancy has not been established; consult your doctor if you are pregnant or planning.

3. Thyroid Concerns – Use cautiously if you have a personal or family history of thyroid tumors or medullary thyroid carcinoma.

FAQs:

Q1: What is MOUNJARO 5MG used for?
A: It is primarily used to improve blood sugar control in adults with type 2 diabetes and to support weight loss.

Q2: Is MOUNJARO suitable for non-diabetics?
A: While it is approved for diabetes, doctors may prescribe it off-label for obesity or metabolic disorders.

Q3: How often should I take MOUNJARO?
A: It is administered once a week, on the same day each week.

Approx. Rs 120 / StripGet Latest Price

Product BrochureProduct Details:

Product Summary

PANTUBE-10000 (PANCREATIN 150MG) is a digestive enzyme supplement designed to aid in the breakdown and absorption of nutrients. It helps improve digestion by supporting the body’s natural enzyme activity. This formulation is especially useful for individuals with enzyme deficiencies or digestive disorders.

Product Full Description

PANTUBE-10000 (PANCREATIN 150MG) contains pancreatin, a blend of digestive enzymes including lipase, amylase, and protease. These enzymes assist in breaking down fats, carbohydrates, and proteins into absorbable nutrients. It supports proper digestion and enhances nutrient absorption in the body. The formulation is commonly used in conditions where the pancreas does not produce enough enzymes. With regular use under medical guidance, it helps maintain digestive health. It is widely recommended for enzyme replacement therapy.

Usage Instructions

1. Take PANTUBE-10000 as prescribed by your healthcare provider.
2. Swallow the capsule whole with water during or immediately after meals.
3. Do not crush or chew the capsule.
4. Follow a consistent schedule with meals for best results.
5. Continue usage as advised by your doctor.

Medicinal Advantages

• Supports digestion of fats, proteins, and carbohydrates
• Enhances nutrient absorption in the body
• Helps manage pancreatic enzyme deficiencies
• Improves overall digestive health
• Useful in enzyme replacement therapy
• Backed by clinical use in gastrointestinal care

Mechanism of Action

PANTUBE-10000 (PANCREATIN 150MG) works by supplying essential digestive enzymes that the pancreas may not produce in sufficient amounts. These enzymes break down complex nutrients into simpler forms, enabling efficient absorption in the intestines and improving digestion.

Off-Label Uses

• Support in chronic digestive discomfort
• Aid in malabsorption conditions
• Used in certain gastrointestinal disorders
• Support for individuals with impaired pancreatic function

Expert Advice

• Use PANTUBE-10000 exactly as prescribed by your doctor
• Take it with meals to maximize effectiveness
• Maintain a balanced diet alongside treatment
• Do not skip doses for consistent digestive support
• Regular medical consultation is recommended

Approx. Rs 2,111 / PieceGet Latest Price

Product Details:

Fondared 7.5 Injection is an anticoagulant medicine used in the treatment of deep vein thrombosis (clot in veins of leg) and pulmonary embolism (clot in artery of lungs). It helps to prevent formation of harmful blood clots in blood vessels.

Fondared 7.5 Injection also reduces the risk of getting

Approx. Rs 1,11,111 / PieceGet Latest Price

Product Details:

Inclisiran 284 mg Injection contains Inclisiran, a small interfering RNA (siRNA) medication used to lower cholesterol levels in the blood. It is specifically indicated for the treatment of hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH) and atherosclerotic cardiovascular disease (ASCVD) in adults who require additional lowering of LDL cholesterol.

Inclisiran is available in a strength of 284 mg per injection and is typically packaged as a single-use pre-filled syringe. This convenient packaging allows for easy administration, usually performed by a healthcare professional.

The active ingredient, Inclisiran, works by targeting and degrading the messenger RNA (mRNA) that encodes for the protein PCSK9 (proprotein convertase subtilisin/kexin type 9). By reducing the production of PCSK9, Inclisiran increases the number of LDL receptors on the surface of liver cells, enhancing the clearance of LDL cholesterol from the blood. This mechanism of action leads to a significant reduction in LDL cholesterol levels.

The usual dosage of Inclisiran involves an initial injection, followed by a second dose at 3 months, and subsequent doses every 6 months. This biannual dosing schedule offers a convenient and effective approach to managing cholesterol levels, especially for patients who may have difficulty adhering to daily medications.

Common side effects of Inclisiran may include injection site reactions, such as redness, pain, or swelling. These side effects are generally mild and temporary. However, any severe or persistent side effects should be reported to a healthcare provider promptly.

Inclisiran is manufactured by Novartis Pharmaceuticals, a leading global healthcare company known for its innovative treatments and commitment to improving patient outcomes. Regular monitoring of cholesterol levels and follow-ups with the healthcare provider are essential to assess the effectiveness of Inclisiran and make any necessary adjustments to the treatment plan.

Inclisiran 284 mg Injection provides a groundbreaking solution for managing high cholesterol levels, particularly in patients with ASCVD and familial hypercholesterolemia. Its novel siRNA mechanism offers a new approach to cholesterol reduction, helping to reduce the risk of cardiovascular events and improve overall cardiovascular health. With its convenient dosing schedule and proven efficacy, Inclisiran represents a significant advancement in lipid management therapy.